Accelrys, Inc. (NASDAQ: ACCL), a leading
provider of scientific business intelligence software and services, is pleased
to announce their blog for the scientific and engineering research community
at http://blog.accelrys.com/.
"Accelrys recently made its entrance into the "blogosphere",
providing an important and valuable way for our experts in key areas of science
to engage in an ongoing, interactive dialogue with the scientific community,"
said Dr. Frank Brown, senior vice president and chief science officer of Accelrys.
"We encourage you to actively engage with our scientists via the Accelrys
Blog by providing comments to blog posts that interest you. If you have comments
or suggestions on blog posts, feel free to let us know by posting a comment."
The blog also gives the scientific and engineering research community a way
to connect with their peers. It addresses subjects in Life Sciences including
cheminformatics, data mining & knowledge discovery, molecular modeling &
simulations, personalized medicine and translational medicine. Subjects in Chemicals,
Materials and Manufacturing include atomic-scale modeling, informatics, materials,
multi-scale modeling and nanotechnology.
In addition to regular weekly postings the Accelrys Blog features a subscription
mechanism for email or RSS (Really Simple Syndication) feed updates. Readers
can comment on or use social bookmarking tools for individual posts.
Bloggers include Dana Honeycutt, PhD., George Fitzgerald, PhD., Gerhard Goldbeck-Wood,
PhD, Max Petersen, PhD., Robert Walker and Shikha Varma-O’Brien, PhD.
Headquartered in San Diego, California, Accelrys develops scientific business
intelligence software and solutions for the life sciences, energy, chemicals,
aerospace, and consumer products industries. Customers include many Fortune
500 companies and other commercial entities, as well as academic and government
entities. Accelrys has a vast portfolio of computer-aided design modeling and
simulation offerings which assist customers in conducting scientific experiments
‘in silico’ in order to reduce the duration and cost of discovering
and developing new drugs and materials. Its scientific business intelligence
platform underlies the company’s computer-aided design modeling and simulation
offerings. The Accelrys platform can be used with both Accelrys and competitive
products, as well as with customers’ proprietary predictive science products.
Its flexibility, ease-of-use and advanced chemical, text and image analysis
and reporting capabilities enable customers to mine, aggregate, analyze and
report scientific data from disparate sources, thereby better utilizing scientific
data within their organizations.
Posted August 20th, 2009
